Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study looking at differences in platelets and how well they work when given as a platelet transfusion (PROmPT)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
More about this trial
Platelets are a type of blood cell. They are very important in blood clotting and help to stop bleeding. If the number of platelets in your blood is low you may bruise easily, have nosebleeds or bleed more than usual from cuts or grazes.
The number of platelets you have may go down when you have cancer treatment such as chemotherapy. If the number of platelets you have gets very low, you may need to have platelets from a donor. You have them through a drip into a vein.
Platelets need to be ‘switched on’ to help with blood clotting. How easily platelets are switched on is called responsiveness. When they are tested in the laboratory, platelets from different donors have different levels of responsiveness. Researchers wanted to find out if these levels make any difference when the platelets are given to another person as a platelet transfusion.
The people taking part in this study had platelet transfusions as part of their treatment.
Summary of results
Despite attempting to contact the trial team, we have not been able to have the results for this trial checked.
How to join a clinical trial
Dr Lorna Williamson
NHS Blood and Transplant
NIHR Clinical Research Network: Cancer